{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:10:06Z","timestamp":1791252606669,"version":"4.1.0"},"reference-count":130,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T00:00:00Z","timestamp":1306454400000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the mid\u20101980s, the treatment of Parkinson's disease was quite exclusively centered on dopatherapy and was focusing on dopamine systems and motor symptoms. A few dopamine agonists and a monoamine oxidase B inhibitor (selegiline) were used as adjuncts in advanced Parkinson's disease. In the early 2010s, levodopa remains the gold standard. New insights into the organization of the basal ganglia paved the way for deep brain stimulation, especially of the subthalamic nucleus, providing spectacular improvement of drug\u2010refractory levodopa\u2010induced motor complications. Novel dopamine agonists (pramipexole, ropinirole, rotigotine), catecholmethyltransferase inhibitors (entacapone), and monoamine oxidase B inhibitors (rasagiline) have also been developed to provide more continuous oral delivery of dopaminergic stimulation in order to improve motor outcomes. Using dopamine agonists early, before levodopa, proved to delay the onset of dyskinesia, although this is achieved at the price of potentially disabling daytime somnolence or impulse control disorders. The demonstration of an antidyskinetic effect of the glutamate antagonist amantadine opened the door for novel nondopaminergic approaches of Parkinson's disease therapy. More recently, nonmotor symptoms (depression, dementia, and psychosis) have been the focus of the first randomized controlled trials in this field. Despite therapeutic advances, Parkinson's disease continues to be a relentlessly progressive disorder leading to severe disability. Neuroprotective interventions able to modify the progression of Parkinson's disease have stood out as a failed therapeutic goal over the last 2 decades, despite potentially encouraging results with compounds like rasagiline. Newer molecular targets, new animal models, novel clinical trial designs, and biomarkers to assess disease modification have created hope for future therapeutic interventions. \u00a9 2011 <jats:italic>Movement<\/jats:italic> Disorder Society<\/jats:p>","DOI":"10.1002\/mds.23714","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T16:09:23Z","timestamp":1307981363000},"page":"1072-1082","source":"Crossref","is-referenced-by-count":162,"title":["Milestones in Parkinson's disease therapeutics"],"prefix":"10.1002","volume":"26","author":[{"given":"Olivier","family":"Rascol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,27]]},"reference":[{"issue":"4","key":"e_1_2_6_2_2","first-page":"S1","article-title":"Management of Parkinson's disease: an evidence\u2010based review","volume":"17","year":"2002","journal-title":"Mov Disord"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08520-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20213"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2007.00818.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20248"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20324"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.25.12.1144"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91416-1"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92939-7"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22022"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.7.949"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100606"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033447"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70521-X"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/107.2.487"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.9.1131"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200213"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130222"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3180ed449f"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000149637.70961.4C"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21500"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000117399"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2007.00035.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20317"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22060"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0622-y"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91193-2"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf214"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10281"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130207"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1978.00500320023005"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.42.2.143"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.6.773"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.5.826"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422004"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.15.1931"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20724"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855001-00004"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15945-X"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20328"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20201"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000258660.74391.c1"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802387130"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23317"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21741"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70108-4"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199903)14:2<350::AID-MDS1024>3.0.CO;2-0"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10365"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01262.x"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10429"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70225-X"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22505"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.65"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20988"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21292"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22890"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.32"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20243"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000152880.77812.5B"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198612000-00001"},{"key":"e_1_2_6_63_2","first-page":"176","article-title":"The Parkinson Study Group","volume":"328","author":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease","year":"1993","journal-title":"N Engl J Med"},{"issue":"4","key":"e_1_2_6_64_2","first-page":"13","article-title":"Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?","volume":"42","author":"Olanow CW","year":"1992","journal-title":"Neurology"},{"key":"e_1_2_6_65_2","first-page":"37","article-title":"Parkinson Study Group","volume":"39","author":"Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa","year":"1996","journal-title":"Ann Neurol"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.12.1937"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20145"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.2.241"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71083-7"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318199068b"},{"key":"e_1_2_6_71_2","first-page":"95","article-title":"Pharmacology and neuroprotective properties of rasagiline","volume":"48","author":"Finberg JP","year":"1996","journal-title":"Journal of neural transmission"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2005.tb00043.x"},{"key":"e_1_2_6_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22218"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809335"},{"issue":"2","key":"e_1_2_6_75_2","first-page":"S47","article-title":"Drug selection and timing of initiation of treatment in early Parkinson's disease","volume":"64","author":"Schapira AH","year":"2008","journal-title":"Ann Neurol"},{"key":"e_1_2_6_76_2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1212\/WNL.0b013e3181d7d94b","article-title":"The delayed\u2010start study in Parkinson disease: can't satisfy everyone","volume":"74","author":"Olanow CW","journal-title":"Neurology"},{"issue":"2","key":"e_1_2_6_77_2","first-page":"S101","article-title":"Why have we failed to achieve neuroprotection in Parkinson's disease?","volume":"64","author":"Olanow CW","year":"2008","journal-title":"Ann Neurol"},{"key":"e_1_2_6_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22432"},{"key":"e_1_2_6_79_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318199049e"},{"key":"e_1_2_6_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.04.034"},{"key":"e_1_2_6_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870040514"},{"key":"e_1_2_6_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20612"},{"key":"e_1_2_6_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)00923-0"},{"key":"e_1_2_6_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1268-7"},{"key":"e_1_2_6_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70214-X"},{"key":"e_1_2_6_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)90002-4"},{"key":"e_1_2_6_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130507"},{"key":"e_1_2_6_88_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007759"},{"key":"e_1_2_6_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(92)90006-O"},{"key":"e_1_2_6_90_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1323"},{"key":"e_1_2_6_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1112"},{"key":"e_1_2_6_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22095"},{"key":"e_1_2_6_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22974"},{"key":"e_1_2_6_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21226"},{"key":"e_1_2_6_95_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000312279.49272.9f"},{"key":"e_1_2_6_96_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22643"},{"key":"e_1_2_6_97_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470713990.ch6"},{"key":"e_1_2_6_98_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041470"},{"key":"e_1_2_6_99_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.050682"},{"key":"e_1_2_6_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70146-2"},{"key":"e_1_2_6_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70194-0"},{"key":"e_1_2_6_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70106-X"},{"key":"e_1_2_6_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21966"},{"key":"e_1_2_6_104_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000336340.89821.b3"},{"key":"e_1_2_6_105_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d55f24"},{"key":"e_1_2_6_106_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1970.32.3.0286"},{"key":"e_1_2_6_107_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.14.4546"},{"key":"e_1_2_6_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/1353-8020(96)00003-X"},{"key":"e_1_2_6_109_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199407000-00031"},{"key":"e_1_2_6_110_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440407"},{"key":"e_1_2_6_111_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2402638"},{"key":"e_1_2_6_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060404"},{"key":"e_1_2_6_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1993.tb00505.x"},{"key":"e_1_2_6_114_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1992.76.1.0053"},{"key":"e_1_2_6_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90062-4"},{"key":"e_1_2_6_116_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810153391603"},{"key":"e_1_2_6_117_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060281"},{"key":"e_1_2_6_118_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907083"},{"key":"e_1_2_6_119_2","first-page":"1205","article-title":"Functional brain tissue transplantation: reversal of lesion\u2010induced rotation by intraventricular substantia nigra and adrenal medulla grafts, with a note on intracranial retinal grafts","volume":"18","author":"Freed WJ","year":"1983","journal-title":"Biol Psychiatry"},{"key":"e_1_2_6_120_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400605"},{"key":"e_1_2_6_121_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1746"},{"key":"e_1_2_6_122_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1747"},{"key":"e_1_2_6_123_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5796-9"},{"key":"e_1_2_6_124_2","first-page":"46","article-title":"[Studies of mechanism of action of apormorphine on Parkinson's tremor.]","volume":"152","author":"Struppler A","year":"1953","journal-title":"Z Klin Med"},{"key":"e_1_2_6_125_2","first-page":"251","article-title":"Apomorphine in Parkinson's disease","volume":"56","author":"Schwab RS","year":"1951","journal-title":"Trans Am Neurol Assoc"},{"key":"e_1_2_6_126_2","article-title":"Der L\u20103,4\u2010Dioxyphenylalanin (=DOPA)\u2010Effekt bei der Parkinson\u2010Akinese","author":"Birkmayer W","year":"1961","journal-title":"Wiener klinische Wochenschrift"},{"key":"e_1_2_6_127_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196702162760703"},{"key":"e_1_2_6_128_2","first-page":"408","volume-title":"Advances in Neurology","author":"Pollak P","year":"1993"},{"key":"e_1_2_6_129_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1996.84.2.0203"},{"key":"e_1_2_6_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91175-T"},{"key":"e_1_2_6_131_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.2.179"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.23714","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.23714","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.23714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:32:59Z","timestamp":1760963579000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.23714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":130,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1002\/mds.23714"],"URL":"https:\/\/doi.org\/10.1002\/mds.23714","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}